Cargando…
Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning
An important goal of biomedical research is to translate basic research findings into practical clinical implementation. Despite the advances in the technology used in drug discovery, the development of drugs for central nervous system diseases remains challenging. The failure rate for new drugs tar...
Autores principales: | Morofuji, Yoichi, Nakagawa, Shinsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499354/ https://www.ncbi.nlm.nih.gov/pubmed/32091330 http://dx.doi.org/10.2174/1381612826666200224112534 |
Ejemplares similares
-
TB-09 MRNA-SEQ FOR PERICYTES FROM IN VITRO BRAIN METASTASIS AND BLOOD-BRAIN BARRIER MODEL
por: Ujifuku, Kenta, et al.
Publicado: (2019) -
Drug Repositioning for Refractory Benign Tumors of the Central Nervous System
por: Tamura, Ryota
Publicado: (2023) -
Characterization of a Primate Blood-Brain Barrier Co-Culture Model Prepared from Primary Brain Endothelial Cells, Pericytes and Astrocytes
por: Watanabe, Daisuke, et al.
Publicado: (2021) -
Fluvoxamine and Amantadine: Central Nervous System Acting Drugs Repositioned for COVID-19 as Early Intervention
por: Rejdak, Konrad, et al.
Publicado: (2022) -
Effects of fasudil on blood–brain barrier integrity
por: Sato, Kei, et al.
Publicado: (2022)